[1]
|
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424. doi: 10.3322/caac.21492 |
[2]
|
Warburg O, Wind F, Negelein E. The metabolism of tumors in the body[J]. J Gen Physiol, 1927, 8: 519-530. doi: 10.1085/jgp.8.6.519 |
[3]
|
Burk D, Schade AL. On respiratory impairment in cancer cells[J]. Science, 1956, 124: 270-272. http://www.cell.com/servlet/linkout?suffix=e_1_5_1_2_150_2&dbid=8&doi=10.1016/j.tem.2013.03.002&key=13351639&cf= |
[4]
|
Orang AV, Petersen J, McKinnon RA, et al. Micromanag-ing aerobic respiration and glycolysis in cancer cells[J]. Mol Metab, 2019, 23: 98-126. doi: 10.1016/j.molmet.2019.01.014 |
[5]
|
Rihan M, Nalla LV, Dharavath A, et al. Pyruvate kinase m2: A metabolic bug in Re-Wiring the tumor microenvironment[J]. Cancer Microenviron, 2019, 12: 149-167. doi: 10.1007/s12307-019-00226-0 |
[6]
|
Dong GC, Mao QX, Xia WJ, et al. PKM2 and cancer: The function of PKM2 beyond glycolysis[J]. Oncol Lett, 2016, 11: 1980-1986. doi: 10.3892/ol.2016.4168 |
[7]
|
Shiroki T, Yokoyama M, Tanuma N, et al. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism[J]. Cancer Sci, 2017, 108: 931-940. doi: 10.1111/cas.13211 |
[8]
|
Hasan D, Gamen E, Abu Tarboush N, et al. PKM2 and HIF-1alpha regulation in prostate cancer cell lines[J]. PLoS One, 2018, 13: e203745. http://www.researchgate.net/publication/327657345_PKM2_and_HIF-1a_regulation_in_prostate_cancer_cell_lines |
[9]
|
Méndez-Lucas A, Li XL, Hu JJ, et al. Glucose catabolism in liver tumors induced by c-MYC can be sustained by various PKM1/PKM2 ratios and pyruvate kinase activities[J]. Cancer Res, 2017, 77: 4355-4364. doi: 10.1158/0008-5472.CAN-17-0498 |
[10]
|
Christofk HR, Vander Heiden MG, Harris MH, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth[J]. Nature, 2008, 452: 230-233. doi: 10.1038/nature06734 |
[11]
|
Wong N, Ojo D, Yan J, et al. PKM2 contributes to cancer metabolism[J]. Cancer Lett, 2015, 356: 184-191. doi: 10.1016/j.canlet.2014.01.031 |
[12]
|
Chen S, Fisher RC, Signs S, et al. Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis[J]. Oncotarget, 2016, 8: 50476-50488. http://www.ncbi.nlm.nih.gov/pubmed/27286264 |
[13]
|
Ying J, Xu Q, Liu BX, et al. The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis[J]. Onco Targets Ther, 2015, 8: 2427-2433. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562727/ |
[14]
|
Wei L, Li K, Pang X, et al. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2[J]. J Exp Clin Cancer Res, 2016, 35: 166. doi: 10.1186/s13046-016-0446-4 |
[15]
|
Hsu MC, Hung WC. Pyruvate kinase M2 fuels multiple aspects of cancer cells: From cellular metabolism, transcriptional regulation to extracellular signaling[J]. Mol Cancer, 2018, 17: 35. doi: 10.1186/s12943-018-0791-3 |
[16]
|
Mukherjee J, Ohba S, See WL, et al. PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells[J]. Int J Cancer, 2016, 139: 99-111. doi: 10.1002/ijc.30041 |
[17]
|
Yang WW, Xia Y, Ji HT, et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation[J]. Nature, 2017, 480: 118-122. http://europepmc.org/articles/PMC3235705 |
[18]
|
Gao XL, Wang HZ, Yang JJ, et al. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase[J]. Mol Cell, 2012, 45: 598-609. doi: 10.1016/j.molcel.2012.01.001 |
[19]
|
Luo WB, Hu HX, Chang R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1[J]. Cell, 2011, 145: 732-744. doi: 10.1016/j.cell.2011.03.054 |
[20]
|
Luo WB, Semenza GL. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells[J]. Oncotarget, 2011, 2: 551-556. doi: 10.18632/oncotarget.299 |
[21]
|
Yang YC, Chien MH, Liu HY, et al. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress[J]. Cancer Lett, 2018, 421: 28-40. doi: 10.1016/j.canlet.2018.01.075 |
[22]
|
Liang J, Cao RX, Wang XJ, et al. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2[J]. Cell Res, 2017, 27: 329-351. doi: 10.1038/cr.2016.159 |
[23]
|
Li J, Yang Z, Zou Q, et al. PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer[J]. Clin Transl Oncol, 2014, 16: 200-207. doi: 10.1007/s12094-013-1063-8 |
[24]
|
Zhan C, Shi Y, Lu C, et al. Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer[J]. Dis Esophagus, 2013, 26: 746-753. http://smartsearch.nstl.gov.cn/paper_detail.html?id=42c237bc7ce4dcbb8fba3c3b0efdf8a8 |
[25]
|
Feng C, Gao Y, Wang CF, et al. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer[J]. J Clin Endocrinol Metab, 2013, 98: E1524-E1533. doi: 10.1210/jc.2012-4258 |
[26]
|
Wang C, Jiang JL, Ji J, et al. PKM2 promotes cell migra-tion and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer[J]. Sci Rep, 2017, 7: 2886. doi: 10.1038/s41598-017-03031-1 |
[27]
|
Li H, Xu HY, Xing R, et al. Pyruvate kinase M2 contri-butes to cell growth in gastric cancer via aerobic glycolysis[J]. Pathol Res Pract, 2019, 215: 152409. doi: 10.1016/j.prp.2019.04.001 |
[28]
|
Wu JY, Hu L, Chen MY, et al. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: Evidence from 16 cohort studies[J]. Onco Targets Ther, 2016, 9: 4277-4288. doi: 10.2147/OTT.S106508 |
[29]
|
Gao YS, Xu DY, Yu GZ, et al. Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer[J]. Int J Clin Exp Pathol, 2015, 8: 9264-9271. http://old.med.wanfangdata.com.cn/viewHTMLEn/PeriodicalPaper_PM26464675.aspx |
[30]
|
Lim JY, Yoon SO, Seol SY, et al. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer[J]. World J Gastroenterol, 2012, 18: 4037-4043. doi: 10.3748/wjg.v18.i30.4037 |
[31]
|
Kato Y, Yashiro M, Noda S, et al. Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma[J]. Br J Cancer, 2010, 102: 898-907. doi: 10.1038/sj.bjc.6605543 |
[32]
|
Kitayama K, Yashiro M, Morisaki T, et al. Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer[J]. Cancer Sci, 2017, 108: 2462-2469. doi: 10.1111/cas.13421 |
[33]
|
Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics[J]. Oncogene, 2010, 29: 625-634. doi: 10.1038/onc.2009.441 |
[34]
|
Melillo G. Targeting hypoxia cell signaling for cancer therapy[J]. Cancer Metastasis Rev, 2007, 26: 341-352. doi: 10.1007/s10555-007-9059-x |
[35]
|
Chen GX, Feng W, Zhang S, et al. Metformin inhibits gastric cancer via the inhibition of HIF1alpha/PKM2 signal-ing[J]. Am J Cancer Res, 2015, 5: 1423-1434. http://europepmc.org/articles/PMC4473320 |
[36]
|
Gao SM, Chen M, Wei W, et al. Crosstalk of mTOR/PKM2 and STAT3/c-Myc signaling pathways regulate the energy metabolism and acidic microenvironment of gastric cancer[J]. J Cell Biochem, 2018. doi: 10.1002/jcb.26915. Epub ahead of print. |
[37]
|
Lu J, Chen M, Gao SM, et al. LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2[J]. Oncol Lett, 2018, 15: 4358-4364. http://europepmc.org/abstract/MED/29541204 |
[38]
|
Wu HL, Medeiros LJ, Young KH. Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances[J]. Blood Rev, 2018, 32: 8-28. doi: 10.1016/j.blre.2017.08.004 |
[39]
|
Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: Function and dysfunction of its modula-tors and targeted therapeutic strategies[J]. Aging (Albany NY), 2016, 8: 603-619. http://pubmedcentralcanada.ca/pmcc/articles/PMC4925817/ |
[40]
|
Kwon OH, Kang TW, Kim JH, et al. Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level[J]. Biochem Biophys Res Commun, 2012, 423: 38-44. doi: 10.1016/j.bbrc.2012.05.063 |